CCJ holder files Rule 144 to sell 4,000 common shares

A holder of CCJ common shares filed a Rule 144 notice to sell 4,000 common shares on the NYSE, with an aggregate market value of $400,680.00.

Accepted by SEC EDGAR 01/05/2026 - 05:46 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A holder of CCJ common shares filed a Rule 144 notice to sell 4,000 common shares on the NYSE, with an aggregate market value of $400,680.00. The filing lists 435,457,978 shares of this class as outstanding, which provides context for the size of the planned sale. The shares to be sold were acquired on 03/03/2023 through the vesting of a long-term incentive (LTI) award, and the payment method is described as cash. The approximate date of sale is given as 01/05/2026, indicating an intention to dispose of these shares on or around that date under Rule 144.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CCJ Form 144 filing disclose?

The filing discloses that a holder of CCJ common shares intends to sell 4,000 shares under Rule 144 on the NYSE, with an aggregate market value of $400,680.00.

How many CCJ shares are planned to be sold under this Rule 144 notice?

The Rule 144 notice covers the planned sale of 4,000 common shares of CCJ with an aggregate market value of $400,680.00.

When were the CCJ shares to be sold under Rule 144 acquired?

The 4,000 common shares to be sold were acquired on 03/03/2023 as shares vested from a long-term incentive (LTI) award, with payment described as cash.

What is the approximate sale date and exchange for the CCJ shares?

The approximate date of sale for the 4,000 CCJ common shares is listed as 01/05/2026, and the securities are to be sold on the NYSE.

How many CCJ common shares are outstanding according to this notice?

The notice states that there are 435,457,978 common shares outstanding, which helps put the planned sale of 4,000 shares into perspective.

Who is responsible for the information in this CCJ Rule 144 notice?

The person for whose account the securities are to be sold represents by signing that they do not know of any material adverse information about the issuer that has not been publicly disclosed and acknowledges that intentional misstatements or omissions constitute Federal criminal violations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002083938
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CAMECO CORP
SEC File Number	001-14228
Address of Issuer	2121 11TH ST W SASKATOON SASKATCHEWAN, CANADA S7M 1J3
Phone	3069566200
Name of Person for Whose Account the Securities are To Be Sold	Mooney Ronald Liam
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Solium Financial Inc. 1500, 800 - 6th Avenue SW Calgary A0 T2P 3G3	4000	400680.00	435457978	01/05/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	03/03/2023	Shares acquired as of vesting of LTI award	Open Market Purchase			4000	03/03/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/05/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Ronald Liam Mooney
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)